Validation of the GATE Software (ValGATE)

University Hospital Tuebingen

Status: Completed

Conditions: Visual Field Defects

Treatments: Procedure: perimetry

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01265628

161/2009BO2 (Other Identifier)

HSC GATE Strategie

Details and patient eligibility

About

Comparison of the differential luminance sensitivity (DLS) values at each test point

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• physical, intellectual and linguistic abilities, in order to understand the test requirements
• spherical ametropia max. ± 8 dpt, cylindrical ametropia max. ± 3 dpt
• distant visual acuity > 10/20
• isocoria, pupil diameter > 3 mm

Exclusion criteria

• pregnancy, nursing
• diabetic retinopathy
• asthma
• HIV+ or AIDS
• history of epilepsy or significant psychiatric disease
• medications known to effect visual field sensitivity
• acute ocular infections (e.g. keratitis, conjunctivitis, uveitis)
• severe dry eyes
• miotic drugs
• amblyopia
• squint
• nystagmus
• albinism
• keratoconus
• intraocular surgery (except for uncomplicated cataract surgery) performed < 3 month prior to screening
• history or presence of macular disease and / or macular edema
• relevant opacities of central refractive media (cornea, lens, vitreous body)
• ocular trauma

Trial design

30 participants in 3 patient groups

Glaucoma

Treatment:

Procedure: perimetry

Retinitis pigmentosa (RP)

Treatment:

Procedure: perimetry

Anterior Ischemic Optic Neuropathy (AION)

Treatment:

Procedure: perimetry